Read + Share
Amedeo Smart
Independent Medical Education
Thaci D, Laquer V, Lynde C, Reich A, et al. Targeting IL-22RA1 with Temtokibart: A Novel Approach in Atopic Dermatitis: Phase 2a Monotherapy Study Results. J Allergy Clin Immunol 2025 Nov 11:S0091-6749(25)01122.PMID: 41232575
Email
LinkedIn
Privacy Policy